domingo, 3 de octubre de 2010
Advisory Committee Calendar > November 3, 2010: Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement
Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting
DATE: November 3, 2010
TIME: 8:00 a.m. to 5:00 p.m.
LOCATION: Hilton Washington D.C. North/Gaithersburg, The Ballrooms, 620 Perry Parkway, Gaithersburg, Maryland
CONTACTS: Diem-Kieu Ngo, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Avenue, WO31-2417, Silver Spring, MD 20993-0002, 301-796-9001, Fax: 301-847-8533, E-mail: diem.ngo@fda.hhs.gov
The committees will discuss a number of safety concerns with intravenous administration of the anti-seizure drugs phenytoin and fosphenytoin, including the condition known as Purple Glove Syndrome (PGS), and recommend what regulatory actions, if any, are necessary to diminish the risks.
Advisory Committee Calendar > November 3, 2010: Joint Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee and Drug Safety and Risk Management Advisory Committee Meeting Announcement
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario